Functional subtypes of renal α1-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension

Acta Pharmacologica Sinica

Volumn 29, Issue 5, 2008, Pages 564-572

  Armenia, A ^a,d   Sattar, Munavvar Abdul ^a   Abdullah, Nor Azizan ^b   Khan, Md Abdul Hye ^a   Johns, Edward James ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d ANDALAS UNIVERSITY   (Indonesia)

Author keywords

2 kidney one clip Goldblatt hypertensive rats; Diabetes; Hypertension; Kidney; Renovascular hypertension

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; METHOXAMINE; NITRENDIPINE; NORADRENALIN; PHENYLEPHRINE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY NERVE; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; RAT STRAIN; RENOVASCULAR HYPERTENSION; STREPTOZOCIN DIABETES; VASOCONSTRICTION;

EID: 42649096690     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00788.x     Document Type: Article

References (40)

1. 1 Hieble JP, Bylund DB, Clark DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, et al. International Union of Pharmacology X. Recommendation for nomenclature of α 1 ‐adrenoceptors: consensus update. Pharmacol Rev 1995 ; 47: 267–70.
2. 2 Bylund DB, Regan JW, Faber JE, Hieble JP, Triggle CR, Rufollo RR. Vascular α‐adrenoceptors: from the gene to the human. Can J Physiol Pharmacol 1995 ; 73: 533–43.
3. 3 Vargas HM, Gorman AJ. Vascular α 1 ‐ adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci 1995 ; 57: 2291–308.
4. 4 Bishop MJ. Recent advances in the discovery of α 1 ‐adrenoceptor agonists. Curr Top Med Chem 2007 ; 7: 135–45.
5. 5 Khan AH, Sattar MA, Abdullah NA, Johns EJ. Influence of cisplatin‐induced renal failure on the alpha (1)‐adrenoceptor subtype causing vasoconstriction in the kidney of the rat. Eur J Pharmacol 2007 ; 569: 110–8.
6. 6 Hye Khan MA, Sattar MA, Abdullah NA, Johns EJ. Cisplatin cause altered renal hemodynamics in rats: role of augmented α‐adrenergic responsiveness. Exp Toxicol Pathol 2007 ; 53: 253–60.
7. 7 Rosini M, Bolognesi ML, Giarrdina D, Minarini A, Tumitatti V, Melchiorre C. Recent advances in α 1 ‐adrenoceptor antagonists as pharmacological tools and therapeutic agents. Curr Top Med Chem 2007 ; 7: 147–62.
8. 8 Moriyama N, Kurooka Y, Nasu K, Akiyama K, Takeuchi T, Nishimatsu H, et al. Distribution of α 1 ‐adrenoceptor subtype mRNA and identification of subtype responsible for renovascular contraction in human renal artery. Life Sci 2000 ; 66: 915–26.
9. 9 Abdul Sattar M, Johns EJ. Alpha 1‐adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one‐clip Goldblatt and deoxycorticosterone acetate‐salt hypertensive rats. J Cardiovasc Pharmacol 1994 ; 24: 420–8.
10. 10 Sattar MA, Johns EJ. Evidence for an α 1 ‐adrenoceptor subtype mediating adrenergic vasoconstriction in Wistar normotensive and SPSHR kidney. J Cardiovasc Pharmacol 1994 ; 23: 232–9.
11. 11 Villalobos‐Molina R, Ibarra M. α 1 ‐adrenoceptor mediating contraction in arteries of normotensive and SH rats are of α 1D ‐ or α 1A ‐subtypes. Eur J Pharmacol 1996 ; 298: 257–63.
12. 12 Villalobos‐Molina R, Lopez‐Guerrero JJ, Ibarra M. α 1D ‐ and α 1A ‐adrenoceptors mediate contraction in rat renal artery. Eur J Pharmacol 1997 ; 322: 225–7.
13. 13 Eltze M, Konig H, Ullrich B, Grebe T. Buspirone functionally discriminates tissues endowed with α 1 ‐adrenoceptor subtypes A, B, D and L. Eur J Pharmacol 1999 ; 378: 69–83.
14. 14 Satoh M, Enomoto K, Takayanagi I, Koike K. Analysis of α 1 ‐adrenoceptor subtypes in rabbit aorta and arteries: regional difference and co‐existence. Eur J Pharmacol 1999 ; 374: 229–40.
15. 15 Salomonsson M, Brannstrom K, Arendshorst WJ. Alpha (1)‐adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am J Physiol 2000 ; 278: F138–47.
16. 16 Porte D, Schwartz MW. Diabetes complications. Why is glucose potentially toxic? Science 1996 ; 272: 699–700.
17. 17 Armenia A, Munavvar AS, Abdullah NA, Helmi A, Johns EJ. The contribution of adrenoceptor subtypes in the renal vasculature of diabetic spontaneously hypertensive rats. Br J Pharmacol 2004 ; 142: 719–26.
18. 18 Abbas SA, Munavvar AS, Abdullah NA, Johns EJ. Involvement of α 1 ‐adrenoceptor subtypes in the cardiac failure in spontaneously hypertensive rats. J Basic Appl Sci 2006 ; 2: 59–69.
19. 19 Abbas SA, Munavvar AS, Abdullah NA, Johns EJ. Role of alpha 1‐adrenoceptor subtypes in renal haemodynamics in heart failure and diabetic SD rats. Can J Pure Appl Sci 2007 ; 1: 21–34.
20. 20 Stassen FR, Maas R, Schiffers, PMH, Janssen GM, De Mey JG. A positive and Reversible relationship between adrenergic nerves and alpha 1A‐adrenoceptors in rat arteries. J Pharmacol Exp Ther 1998 ; 284: 399–405.
21. 21 Elhawary AM, Pettinger WA, Wolff DW. Subtype‐selective α 1‐ adrenoceptor alkylation in the rat kidney and its effect on the vascular pressor response. J Pharmacol Exp Ther 1992 ; 260: 709–13.
22. 22 Villalobos‐Molina R, Lopez‐Guerrero JJ, Ibarra M. Functional evidence of α 1D ‐adrenoceptors in vasculature of young and adults spontaneously hypertensive rats. Br J Pharmacol 1999 ; 126: 1534–6.
23. 23 Blue DR, Vimont RL, Clarke DE. Evidence for a noradrenergic innervation to α 1A ‐adrenoceptors in rat kidney. Br J Pharmacol 1992 ; 107: 414–7.
24. 24 Blue DR, Bonchaus DW, Ford APDW, Pfister JR, Syarif NA, Shieh IA, et al. Functional evidence equating the pharmacologically‐defined α 1A ‐ and cloned α 1C ‐adrenoceptor: studies in isolated perfused kidney of rat. Br J Pharmacol 1995 ; 115: 283–94.
25. 25 Perez DM, Piascik MT, Malik N, Gaivin R, Graham RM. Cloning, expression, and tissue distribution of the rat homolog of the bovine α 1C ‐adrenergic receptor provide evidence for its classification as the α 1A ‐subtype. Pharmacology 1994 ; 46: 823–31.
26. 26 Zhu W, Zhang Y, Han C. Characterization of subtype α 1 ‐adrenoceptor mediating vasoconstriction in perfused rat hind limb. Eur J Pharmacol 1997 ; 329: 55–61.
27. 27 Hrometz SL, Edelmann SE, McCune DF, Olges JR, Hadley RW, Perez DM, et al. Expression of multiple α 1 ‐adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 1999 ; 290: 452–63.
28. 28 Maeda CY, Fernandes TG, Timm HB, Irigoyen MC. Autonomic dysfunction in short‐term experimental diabetes. Hypertension 1995 ; 26: 1100–4.
29. 29 Schaan BD, Dall'Ago P, Maeda CY, Ferlin E, Fernandes TG, Schmid H, et al. Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin‐induced diabetes in rats. Braz J Med Biol Res 2004 ; 37: 1895–902.
30. 30 Maeda CY, Fernandes TG, Lulhier F, Irigoyen MC. Streptozotocin diabetes modifies arterial pressure and baroreflex sensitivity in rats. Braz J Med Biol Res 1995 ; 28: 497–501.
31. 31 Jarajapu YPR, Hillier C, MacDonald A. The α 1A ‐adrenoceptor subtypes mediate contraction in rat femoral resistance arteries. Eur J Pharmacol 2000 ; 422: 127–35.
32. 32 Zacharia J, Hillar C, MacDonald A. α 1 ‐adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released in rat femoral resistance arteries. Br J Pharmacol 2004 ; 141: 915–24.
33. 33 Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, Tsujimoto G. Subtype‐species differences in sub‐cellular localization of α 1 ‐adrenoceptors: chloroethylclonidine preferentially alkylates the accessible cell surface α 1 ‐adrenoceptors irrespective of the subtype. Mol Pharmacol 1997 ; 52: 764–70.
34. 34 Yang M, Reese J, Cotecchia S, Michel MC. Murine alpha 1‐adrenoceptor subtypes. I. Radioligand binding studies. J Pharmacol Exp Ther 1998 ; 286: 841–7.
35. 35 Gómez‐Zamudio J, Lázaro‐Suárez ML, Villalobos‐Molina R, Urquiza‐Marín H. Evidence for the use of agonists to characterize α 1 ‐ adrenoceptors in isolated arteries of the rat. Proc West Pharmacol Soc 2002 ; 45: 159–60.
36. 36 Arévalo‐León LE, Gallardo‐Ortíz IA, Urquiza‐Marín H, Villalobos‐Molina R. Evidence for the role of alpha 1D ‐ and α 1A ‐adrenoceptors in contraction of rat mesenteric artery. Vascul Pharmacol 2003 ; 40: 9196.
37. 37 Li Z, Silver WP, Koman LA, Strandhoy JW, Rosencrance E, Gordon S, et al. Role of α 1A ‐adrenoceptor subtypes mediating constriction of the rabbit ear thermoregulatory microvasculature. J Orthop Res 2000 ; 18: 156–63.
38. 38 Stassen FR, Willemsen MJ, Janssen GM, De Mey JG. Alpha 1‐adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post‐myocardial infarction. Cardiovasc Res 1997 ; 33: 706–13.
39. 39 Goetz AS, King HK, Ward SD, True TA, Rimele TJ, Saussy DL. BMY 7378 is a selective antagonist of the D subtype of α 1 ‐adrenoceptors. Eur J Pharmacol 1995 ; 272: R5–R6.
40. 40 Zhou L, Varga S. Vascular α 1D ‐adrenoceptors have a role in the pressor response to phenylephrine in pithed rat. Eur J Pharmacol 1996 ; 305: 173–6.